{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:33:37Z","timestamp":1784691217535,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":3012,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE140101097"],"award-info":[{"award-number":["DE140101097"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001077","name":"Royal Brisbane and Women's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018897","name":"Lions Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1017\/s104161021600096x","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T06:10:14Z","timestamp":1467612614000},"page":"1597-1614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Management of impulse control disorders in Parkinson's disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Susan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeeka N.","family":"Dissanayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-5040","authenticated-orcid":false,"given":"Andrew","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S104161021600096X_bb0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/jnnp-2013-307214","article-title":"Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up","volume":"86","author":"Amami","year":"2014","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association.","year":"2013"},{"key":"10.1017\/S104161021600096X_bb0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.47.3.626","article-title":"Reversible parkinsonism and cognitive impairment with chronic valproate use","volume":"47","author":"Armon","year":"1996","journal-title":"Neurology"},{"key":"10.1017\/S104161021600096X_bb0025","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","article-title":"Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation","volume":"21","author":"Ardouin","year":"2006","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","article-title":"Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease","volume":"165","author":"Ardouin","year":"2009","journal-title":"Revue Neurologique"},{"key":"10.1017\/S104161021600096X_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"The Lancet Neurology"},{"key":"10.1017\/S104161021600096X_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.parkreldis.2007.11.008","article-title":"Topiramate in managing impulse control disorders in Parkinson's disease","volume":"14","author":"Bermejo","year":"2008","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1017\/S104161021600096X_bb0045","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00415-010-5603-7","article-title":"Zonisamide in managing impulse control disorders in Parkinson's disease","volume":"257","author":"Bermejo","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1017\/S104161021600096X_bb0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e3182549c2a","article-title":"Finasteride attenuates pathological gambling in patients with Parkinson disease","volume":"32","author":"Bortolato","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1017\/S104161021600096X_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.parkreldis.2011.02.013","article-title":"Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review","volume":"17","author":"Broen","year":"2011","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1017\/S104161021600096X_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JPD-120165","article-title":"A systematic review of impulse control disorders in Parkinson's disease","volume":"3","author":"Callesen","year":"2013","journal-title":"Journal of Parkinson's Disease"},{"key":"10.1017\/S104161021600096X_bb0065","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/nn.2925","article-title":"Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold","volume":"14","author":"Cavanagh","year":"2011","journal-title":"Nature Neuroscience"},{"key":"10.1017\/S104161021600096X_bb0070","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1586\/ern.12.142","article-title":"Drug treatments for the neuropsychiatric complications of Parkinson's disease","volume":"12","author":"Connolly","year":"2012","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1017\/S104161021600096X_bb0075","first-page":"CD003467","article-title":"Amantadine for dyskinesia in Parkinson's disease","volume":"2","author":"Crosby","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S104161021600096X_bb0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neuron.2009.01.031","article-title":"Personality, addiction, dopamine: insights from Parkinson's disease","volume":"61","author":"Dagher","year":"2009","journal-title":"Neuron"},{"key":"10.1017\/S104161021600096X_bb0085","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10880-012-9302-7","article-title":"Impulse control disorders in Parkinson's disease: a psychosocial perspective","volume":"19","author":"Delaney","year":"2012","journal-title":"Journal of Clinical Psychology in Medical Settings"},{"key":"10.1017\/S104161021600096X_bb0090","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021600096X_bb0095","first-page":"399","article-title":"Chapter 19 - The basal ganglia in reward and decision making: computational models and empirical studies","author":"Dreher","year":"2009"},{"key":"10.1017\/S104161021600096X_bb0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp-2012-302387","article-title":"Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease","volume":"84","author":"Eusebio","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.870130338","article-title":"Clozapine for dopaminergic-induced paraphilias in Parkinson's disease","volume":"13","author":"Fernandez","year":"1998","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0115","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.1146157","article-title":"Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism","volume":"318","author":"Frank","year":"2007","journal-title":"Science"},{"key":"10.1017\/S104161021600096X_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000381558","article-title":"The influence of bilateral subthalamic nucleus deep brain stimulation on impulsivity and prepulse inhibition in Parkinson's disease patients","volume":"93","author":"Gee","year":"2015","journal-title":"Stereotactic and Functional Neurosurgery"},{"key":"10.1017\/S104161021600096X_bb0125","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","article-title":"Dopamine receptor agonists in current clinical use: comparative receptor binding profiles defined in the human striatum","volume":"110","author":"Gerlach","year":"2003","journal-title":"Journal of Neural Transmission"},{"key":"10.1017\/S104161021600096X_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","article-title":"Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study","volume":"197","author":"Grant","year":"2010","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"key":"10.1017\/S104161021600096X_bb0140","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cub.2013.07.001","article-title":"Reduction of influence of task difficulty on perceptual decision making by STN deep brain stimulation","volume":"23","author":"Green","year":"2013","journal-title":"Current Biology"},{"key":"10.1017\/S104161021600096X_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: Comparison with D2 receptor expressing neurons.","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1017\/S104161021600096X_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2008.02509.x","article-title":"Subthalamic deep brain stimulation and impulse control in Parkinson's disease","volume":"16","author":"Halbig","year":"2009","journal-title":"European Journal of Neurology"},{"key":"10.1017\/S104161021600096X_bb0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/13554794.2012.713490","article-title":"Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson's disease","volume":"19","author":"Hardwick","year":"2013","journal-title":"Neurocase"},{"key":"10.1017\/S104161021600096X_bb0160","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.4674-12.2013","article-title":"The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for Basal Ganglia models and deep brain stimulation","volume":"33","author":"Haynes","year":"2013","journal-title":"Journal of Neuroscience"},{"key":"10.1017\/S104161021600096X_bb0165","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/01.WNL.0000118202.19098.10","article-title":"Stimulation of STN impairs aspects of cognitive control in PD","volume":"62","author":"Hershey","year":"2004","journal-title":"Neurology"},{"key":"10.1017\/S104161021600096X_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.parkreldis.2011.03.003","article-title":"Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease","volume":"17","author":"Hicks","year":"2011","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1017\/S104161021600096X_bb0175","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathologic gambling","volume":"47","author":"Hollander","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.mjt.0000151861.59698.26","article-title":"Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: a single case study","volume":"12","author":"Ivanco","year":"2005","journal-title":"American Journal of Therapeutics"},{"key":"10.1017\/S104161021600096X_bb0185","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/brain\/awu117","article-title":"Targeting impulsivity in Parkinson's disease using atomoxetine","volume":"137","author":"Kehagia","year":"2014","journal-title":"Brain"},{"key":"10.1017\/S104161021600096X_bb0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease","volume":"19","author":"Kurlan","year":"2004","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2011.11.082","article-title":"Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging","volume":"60","author":"Lambert","year":"2012","journal-title":"Neuroimage"},{"key":"10.1017\/S104161021600096X_bb0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22289","article-title":"Is pathological gambling in Parkinson's disease reduced by amantadine?","volume":"69","author":"Lee","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1017\/S104161021600096X_bb0205","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours","volume":"135","author":"Lhommee","year":"2012","journal-title":"Brain"},{"key":"10.1017\/S104161021600096X_bb0210","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1212\/WNL.0000000000001458","article-title":"Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","volume":"84","author":"Liang","year":"2015","journal-title":"Neurology"},{"key":"10.1017\/S104161021600096X_bb0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1444.006","article-title":"Impulse control and related disorders in Parkinson's disease: review","volume":"1142","author":"Lim","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1017\/S104161021600096X_bb0220","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","article-title":"Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease","volume":"16","author":"Lim","year":"2009","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1017\/S104161021600096X_bb0225","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archneur.63.2.298-a","article-title":"Gambling and Parkinson disease","volume":"63","author":"Lu","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021600096X_bb0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.12968\/hmed.2013.74.3.160","article-title":"Managing impulse control behaviours in Parkinson's disease: practical guidelines","volume":"74","author":"Macphee","year":"2013","journal-title":"British Journal of Hospital Medicine"},{"key":"10.1017\/S104161021600096X_bb0235","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/mds.22824","article-title":"Clinical follow up of pathological gambling in Parkinson's disease in the West Scotland study","volume":"24","author":"Macphee","year":"2009","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long-term follow-up of impulse control disorders in Parkinson's disease","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0245","first-page":"242","article-title":"Compulsive buying: a report of 20 cases","volume":"55","author":"McElroy","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1756285613476127","article-title":"Diagnosis and treatment of impulse control disorders in patients with movement disorders","volume":"6","author":"Mestre","year":"2013","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1017\/S104161021600096X_bb0255","doi-asserted-by":"crossref","first-page":"e29768","DOI":"10.1371\/journal.pone.0029768","article-title":"Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome","volume":"7","author":"Moum","year":"2012","journal-title":"PLoS One"},{"key":"10.1017\/S104161021600096X_bb0260","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40266-013-0090-z","article-title":"Dopamine agonist withdrawal syndrome: implications for patient care","volume":"30","author":"Nirenberg","year":"2013","journal-title":"Drugs & Aging"},{"key":"10.1017\/S104161021600096X_bb0265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0270","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00221-011-2736-6","article-title":"Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease","volume":"212","author":"Obeso","year":"2011","journal-title":"Experimental Brain Research"},{"key":"10.1017\/S104161021600096X_bb0275","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/mds.26108","article-title":"Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease","volume":"30","author":"Okai","year":"2015","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0280","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","article-title":"Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers","volume":"80","author":"Okai","year":"2013","journal-title":"Neurology"},{"key":"10.1017\/S104161021600096X_bb0285","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","article-title":"Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","volume":"83","author":"Papay","year":"2014","journal-title":"Neurology"},{"key":"10.1017\/S104161021600096X_bb0290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1997.03550020057038","article-title":"Safety and efficacy of pramipexole in early Parkinson disease","volume":"278","author":"Parkinson Study Group","year":"1997","journal-title":"JAMA"},{"key":"10.1017\/S104161021600096X_bb0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021600096X_bb0300","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.23177","article-title":"Clozapine for medication-related pathological gambling in Parkinson disease","volume":"25","author":"Rotondo","year":"2010","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002826-199706000-00003","article-title":"Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease","volume":"20","author":"Ruggieri","year":"1997","journal-title":"Clinical Neuropharmacology"},{"key":"10.1017\/S104161021600096X_bb0310","first-page":"1","article-title":"Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia","volume":"29","author":"Schneider","year":"2013","journal-title":"European Psychiatry: The Journal of the Association of European Psychiatrists"},{"key":"10.1017\/S104161021600096X_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00001","article-title":"Impulse control disorders: updated review of clinical characteristics and pharmacological management","volume":"2","author":"Schreiber","year":"2011","journal-title":"Front Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0320","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1205158","article-title":"Neurostimulation for Parkinson's disease with early motor complications","volume":"368","author":"Schuepbach","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"Suppl. 3","key":"10.1017\/S104161021600096X_bb0325","first-page":"S42","article-title":"The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JCP.0b013e31802e98c3","article-title":"Quetiapine in a case with Parkinson disease and pathological gambling","volume":"27","author":"Sevincok","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1017\/S104161021600096X_bb0335","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2011.08.016","article-title":"Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review","volume":"18","author":"Shotbolt","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1017\/S104161021600096X_bb0340","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jocn.2008.11.026","article-title":"Deep brain stimulation for Parkinson's disease: Australian referral guidelines","volume":"16","author":"Silberstein","year":"2009","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1017\/S104161021600096X_bb0345","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.2006.102061","article-title":"Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease","volume":"78","author":"Smeding","year":"2007","journal-title":"Journal of Neurology Neurosurgery & Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0350","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1017\/S104161021600096X_bb0355","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.parkreldis.2010.02.006","article-title":"Long term follow-up of Parkinson's disease patients with impulse control disorders","volume":"16","author":"Sohtaoglu","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1017\/S104161021600096X_bb0360","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/15622971003671628","article-title":"The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of paraphilias","volume":"11","author":"Thibaut","year":"2010","journal-title":"The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"key":"10.1017\/S104161021600096X_bb0365","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.jcbfm.9600425","article-title":"STN stimulation alters pallidal-frontal coupling during response selection under competition","volume":"27","author":"Thobois","year":"2007","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1017\/S104161021600096X_bb0370","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1017\/S104161021600096X_bb0375","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1017\/S104161021600096X_bb0380","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.870130302","article-title":"Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience","volume":"13","author":"Trosch","year":"1998","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S104161021600096X_bb0385","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1017\/S104161021600096X_bb0390","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021600096X_bb0395","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case control study","volume":"69","author":"Voon","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1017\/S104161021600096X_bb0400","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/mds.23964","article-title":"Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine","volume":"27","author":"Walsh","year":"2012","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"Suppl. 2","key":"10.1017\/S104161021600096X_bb0405","first-page":"S93","article-title":"Dopamine and impulse control disorders in Parkinson's disease","volume":"64","author":"Weintraub","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1017\/S104161021600096X_bb0410","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021600096X_bb0415","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1017\/S104161021600096X_bb0420","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1017\/S104161021600096X_bb0425","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archneur.61.5.697","article-title":"Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease","volume":"61","author":"Witt","year":"2004","journal-title":"Archives of Neurology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224009025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224009025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S104161021600096X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:31:22Z","timestamp":1762353082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224009025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":84,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1041610224009025"],"URL":"https:\/\/doi.org\/10.1017\/s104161021600096x","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of impulse control disorders in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S104161021600096X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}